Rytlewski, J. D., Lanning, R. M., Thorpe, S. W., Donaldson, N., McCarter, M., Chiaro, M. D., Mungo, B., Elias, A. D., Maleddu, A., Becker, E., Clay, M., Wilky, B. A. (2026). Single-institution clinical outcomes with pembrolizumab plus neoadjuvant radiation (SARC032 regimen) with or without neoadjuvant doxorubicin/ifosfamide in high grade soft tissue sarcomas.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e23552